feed,title,long_url,short_url
Motley,Halozyme Therapeutics: A 6.3 Rating and a Future Full of Uncertainty,https://www.fool.com/investing/2026/01/19/halozyme-therapeutics-a-63-rating-and-a-future-ful/?source=iedfolrf0000001,
